Dabigatran Etexilate Mesylate (CAS 872728-81-9) Suppliers and Product Information

Dabigatran etexilate mesylate is a prodrug of dabigatran, a direct thrombin inhibitor and anticoagulant. It is used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. The compound has anticoagulant properties and can prevent venous thromboembolism.

Frequently Asked Questions

Q: What is the main use of Dabigatran Etexilate Mesylate?

A: Dabigatran Etexilate Mesylate is primarily used as an anticoagulant to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Q: How does Dabigatran Etexilate Mesylate work?

A: Dabigatran etexilate mesylate is a prodrug that is metabolized in the body and converted to the active form, dabigatran. It acts as a direct thrombin inhibitor, preventing the formation of blood clots.

Q: What are the common side effects of Dabigatran Etexilate Mesylate?

A: The most common adverse reactions to Dabigatran Etexilate Mesylate (150 mg) include bleeding and gastrointestinal events such as dyspepsia, nausea, epigastric pain, gastrointestinal bleeding, and diarrhea. Rarely, some patients may experience drug hypersensitivity reactions.

Q: How should Dabigatran Etexilate Mesylate be stored?

A: Dabigatran Etexilate Mesylate should be stored in a refrigerator.